Full-Time

Associate Director

Automation Control Systems

Posted on 4/16/2025

Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Senior, Expert

Company Historically Provides H1B Sponsorship

Devens, MA, USA

Site-essential roles require 100% of shifts onsite at your assigned facility.

Category
Robotics and Automation Engineering
Mechanical Engineering
Requirements
  • Minimum educational qualification of a bachelor’s degree in Engineering or Physical Sciences.
  • A minimum of 10 years of control systems experience including greater than 5 years leading major process automation projects, documented by a solid history of technical accomplishments and a proven track record of designing and developing control system software.
  • A minimum of 4 years in a manager role with a history of hiring, developing and retaining key talent.
  • Mastery of engineering principles as enumerated in ISA S88 Batch Process Control and the utilization of recipe driven production systems.
  • Proven experience including implementation of distributed control systems (DeltaV or similar), Building Automation Systems (Rockwell or similar), Manufacturing Execution Systems (Syncade or similar), EBR and data historian tools (PI or similar).
  • Demonstrated understanding of engineering documentation such as P&IDs, Process Flow diagrams and Standard Operating Procedures.
  • Strong knowledge of cGMP particularly, preferably as it applies to biologics manufacturing, small molecule manufacturing (drug substance/drug product), and automated systems.
  • Proven ability working in a matrix environment and leading multi-level/cross functional teams to achieve the highest performance in meeting site and departmental objectives.
  • Ability to work in a diverse group.
  • Ability to manage multiple priorities with tight timeline.
  • Excellent project management skills.
  • Experienced documentation and technical writing skills.
  • Demonstrated creative problem-solving skills.
  • Strong interpersonal skills in teamwork and collaboration.
  • Understand computer system validation.
  • Strong attention to safety a must.
Responsibilities
  • Promote a safe and compliant environment and mindset.
  • Lead the Control Systems project portfolio planning activities and requirement sessions while partnering with internal customers and stakeholders (Manufacturing, Quality, Project Management Office, and Site Engineering).
  • Support the operation of all GMP and non-GMP automation control systems and other auxiliary equipment at the responsible buildings.
  • Lead a team of engineers to investigate, design, configure, integrate and test process control solutions to meet the needs for project and operational support.
  • Periodically review, specify and revise Biologics Automation standards for both control system hardware and software.
  • Collaborate with enterprise-wide control system groups to develop best practices and share knowledge across sites.
  • Effectively tracks project progress to address priorities, meet schedules, maximize productivity, reduce costs, and increase efficiencies.
  • Provide updates to management through established tools and project dashboard.
  • Develop Automation Control System staff through assignment of development opportunities, coaching, mentoring, and effective administration of rewards and recognition programs.
  • Participate in the design of training plans of Automation Control Systems staff and contractor.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high safety and quality standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery accelerates BMS's R&D, improving drug development efficiency.
  • BMS's acquisition of 2seventy bio enhances its cancer cell therapy capabilities.
  • Positive Phase 3 trial results for Sotyktu boost BMS's psoriatic arthritis treatment portfolio.

What critics are saying

  • Increased competition in oncology may impact BMS's market share.
  • Layoffs could decrease employee morale, affecting operational efficiency.
  • Integration challenges from acquiring 2seventy bio may pose financial risks.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company integrates AI in early lung cancer diagnosis, enhancing precision care.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

European HHHM
Apr 16th, 2025
Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis

Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has entered an agreement with Bristol Myers Squibb (NYSE: BMY), to leverage AI in early diagnosis and precision lung cancer care.

CMMB
Mar 24th, 2025
Our Values, Your Impact

In partnership with Bristol Myers Squibb, Catholic Medical Mission Board Inc. is playing a role in building the infrastructure and workforce to bring quality cancer care to rural Kenya.

PR Newswire
Mar 20th, 2025
Bristol Myers Squibb Appoints Osama Braiwish As General Manager For Saudi Arabia Gulf Countries

RIYADH, Saudi Arabia, March 20, 2025 /PRNewswire/ -- Bristol Myers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General Manager for Saudi Arabia and Gulf Countries, an affiliate covering Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan

Investors Hangout
Mar 20th, 2025
Bristol Myers Squibb Welcomes New Leadership in Gulf Region

Bristol Myers Squibb, a leader in the global biopharmaceutical sector, has appointed Osama Braiwish as its General Manager for the Gulf region, thereby enhancing its capacity to serve medical needs across various specialties.

Business Wire
Mar 12th, 2025
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all

INACTIVE